ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.80425
0.06%
Brent Oil
84.145
0.23%
Bitcoin
63,196.73
0.24%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ARYA Sciences Acquistion Corporation III (ARYA)

  7. ARYA Sciences Acquistion Corporation III (ARYA) Noticias

ARYA

ARYA Sciences Acquistion... (ARYA)

ARYA Sciences Acquistion Corporation III
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARYA
FechaHoraFuenteTítuloSímboloCompañía
21/06/202305:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
02/05/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
27/04/202315:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
27/04/202315:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/03/202314:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
23/02/202315:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
23/02/202315:13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
13/02/202315:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/11/202215:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/11/202205:10Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
09/08/202215:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
09/08/202205:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
02/08/202215:28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/07/202216:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
15/04/202216:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
22/06/202115:59Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
21/06/202116:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
14/06/202105:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
09/06/202121:05GlobeNewswire Inc.Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human ProteomeNASDAQ:ARYAARYA Sciences Acquistion Corporation III
08/06/202116:14Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/06/202116:01GlobeNewswire Inc.ARYA Sciences Acquisition Corp III Announces Extraordinary General Meeting Teleconference DetailsNASDAQ:ARYAARYA Sciences Acquistion Corporation III
13/05/202105:08Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
26/03/202116:25Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
13/07/202008:19Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ARYAARYA Sciences Acquistion Corporation III
02/07/202006:00GlobeNewswire Inc.Immatics Announces Completion of Business Combination and Listing on NASDAQNASDAQ:ARYAARYA Sciences Acquistion Corporation III
01/07/202015:23Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ARYAARYA Sciences Acquistion Corporation III
29/06/202016:34Business WireArya Sciences Acquisition Corp. Shareholders Approve Business Combination Transaction with ImmaticsNASDAQ:ARYAARYA Sciences Acquistion Corporation III
 Showing the most relevant articles for your search:NASDAQ:ARYA

Su Consulta Reciente

COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
CCOM
US500
US 500
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
FX
USDMXN
US Dollar vs MXN
CCOM
OILBRENT
Brent Oil
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados